Lv4
418 积分 2022-12-06 加入
The Systemic Lupus Erythematosus Responder Index (SRI); A new SLE disease activity assessment
15天前
已完结
2025 American College of Rheumatology ( ACR ) Guideline for the Treatment of Systemic Lupus Erythematosus
15天前
已完结
Validation of the revised definition of lupus low disease activity in patients with SLE
15天前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
23天前
已完结
Spectrum, pathobiology, mechanistic insights and diagnostic challenges of post-CAR T cell therapy lymphoproliferative disorders
1个月前
已完结
Optimizing CAR T cell therapy for solid tumours: a clinical perspective
1个月前
已完结
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models
2个月前
已完结
The analysis of the functions of human B and T cells in humanized NOD/shi-scid/γcnull (NOG) mice (hu-HSC NOG mice)
4个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
5个月前
已完结
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases
5个月前
已完结
皖公网安备34019202002308
